Taysha Gene Therapies Inc
NASDAQ:TSHA
Taysha Gene Therapies Inc
NASDAQ:TSHA
Price:
1.72
USD
Market Closed
Market Cap:
352.6m
USD
P/OCF
Price to OCF
Price to OCF
-4.3
Current
-3.8
Median
19.8
Industry
Lower
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=-4.3
Market Cap
/
352.5m USD
Operating Cash Flow
-81.2m USD
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
